A radioimmunoassay was developed to detect the cholecystokinin (CCK)-associated nonapeptide (CAP-9) that forms the COOH terminus of pig preproCCK. This peptide (Ser-Ala-Glu-Glu-Tyr-Glu-Tyr-Thr-Ser) is presumably produced at the time that the tyrosine-sulfated octapeptide CCK8(s) is cleaved from preproCCK. Radioimmunoassay of a dried methanol extract of pig brain revealed no detectable CAP-9 immunoreactivity, whereas acid desulfation of the dried methanol extract prior to radioimmunoassay resulted in easily measurable concentrations of CAP-9 immunoreactivity. Two peptides, CAP-9 and des-Ser9-CAP-9, were purified from a methanol extract of 8 kg of commercially obtained whole pig brains. Amino acid analysis showed that each peptide has both tyrosines sulfated. Thus, the likely sequence of CCK posttranslational processing events is sulfation ofthe three tyrosines in the COOH terminus of preproCCK followed by peptide cleavage and appearance of CCK8(s) and CAP-9(s,s).
Cholecystokinin (CCK) is unique among the brain-gut peptides in that comparable concentrations of immunoreactive CCK are found in both anatomical locations (1) (2) (3) (4) (5) (6) . However, the distribution of molecular forms differs between brain and duodenum. Pig brain contains primarily the CCK COOHterminal octapeptide (CCK8) and the desoctapeptides of several larger forms: CCK33, CCK39, and CCK58 (7) . In the duodenum the intact larger forms and desoctapeptides are about equally prominent (8) . CCK8 in both brain and gut has an O-sulfated tyrosine in position 7 from the COOH terminus and a COOH-terminal phenylalanine amide.
The cDNA sequences encoding preproCCK are now known for rat (9) , pig (10), man (11) , and mouse (12) . All of them predict a Gly-Arg-Arg bridge to a nine amino acid peptide located on the COOH terminus of preproCCK. This CCK-associated nonapeptide (CAP-9), which in pig has the sequence Ser-Ala-Glu-Glu-Tyr-Glu-Tyr-Thr-Ser (10), should appear simultaneously with the formation of CCK8. It has recently been noted that O-sulfation of tyrosine residues in peptide sequences frequently occurs in tyrosines preceded by or in the vicinity of acidic amino acids (13) . Since CAP-9 has two tyrosines, both of which are preceded by acidic amino acids, we hypothesized that one or both of these tyrosines might be sulfated. In this report we describe the purification, amino acid analysis, and sequence of the COOH-terminal nonapeptide of pig preproCCK and demonstrate that in pig brain the tyrosines of CAP-9 are fully sulfated. In addition we show that there is a fully sulfated octapeptide of the same sequence but lacking the COOH-terminal serine.
MATERIALS AND METHODS
Radioimmunoassay (RIA). CAP-9 was synthesized on a solid-phase support. The synthetic CAP-9 was dissolved in phosphate buffer and conjugated to thyroglobulin with glutaraldehyde at a ratio of 1.25 mg per 13 mg, respectively. The conjugate was purified on a small Sephadex G-25 column and was used to immunize each of two rabbits at monthly intervals with =100 ug of conjugated CAP-9. After the third immunization, antiserum from rabbit 8393 could be used in an RIA at a final dilution of 1:100,000 after overnight incubation at 4°C. CAP-9 was labeled with 1251 to a specific activity of 150 ,Ci/,ug (1 Ci = 37 GBq) by using the chloramine-T technique generally employed in our laboratory (14) with a minor modification. Purification ofthe 125I-labeled CAP-9 (125I-CAP-9) was effected by adsorption to a C18 Sep-Pak cartridge (Waters Associates) and elution with 2 ml 20% ethanol/0.01 M HCl. Pig tissue extract or aliquots of fractions from the purification steps were assayed both directly and after desulfation. To desulfate, the sample was dried, 250 ,ul of 0.5 M HCl was added, and the solution was heated at 100°C for 5 min. The HCl was removed by lyophilization and the sample was redissolved in assay buffer prior to assay. The assay buffer was 0.02 M sodium barbital, pH 8.4, containing bovine albumin at 1 mg/ml.
Purification. Eight kilograms of whole pig brains was purchased frozen from a local butcher. The tissue was divided into 200-g aliquots and each was extracted with 5 vol of methanol in a Waring blender. The suspensions were filtered through Whatman no. 1 filter paper and yielded 35 liters of methanol extract. The methanol extract was pumped through a 350-ml column of DEAE-cellulose (Whatman DE-52) that had been equilibrated and packed in 80% methanol. The column was then washed with 1 liter of 0.05 M Tris HCl, pH 7, and eluted with a 2.4-liter linear gradient from 0 to 1 M NaCl in the Tris buffer. Thirty-milliliter fractions were collected. Small aliquots from each fraction were assayed both directly and after desulfation. The peak fractions as determined by RIA of the desulfated aliquots were pooled. The pool was acidified by the addition of trifluoroacetic acid to a final concentration of 0.1%, and one-quarter ofthe pool was then purified by a series of HPLC steps consisting of the following columns and elution conditions. The flow rate at each step was 1 ml/min: (i) ,Bondapak by the number of amino acid residues they contain (e.g., CCK8); (s), sulfated tyrosine; CAP-9, CCK-associated COOH-terminal nonapeptide.
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pool of immunoreactive CAP-9 was purified in a similar manner.
Amino Acid Analysis and Sequencing. Each purified peptide was subjected to amino acid analysis and sequencing, using 100 and 325 pmol, respectively. Amino acid analysis of each purified peptide was performed on a fluorescamine analyzer (15) after 6 M HCl hydrolysis as well as enzyme hydrolysis using leucine aminopeptidase (Boehringer-Mannheim, 5 Ag of enzyme per 300 pmol of peptide in 100 4l of 0.2 M NH4HCO3 containing 2.5 mM MgCl2). The elution position of tyrosine-O-sulfate was verified by analyzing an aminopeptidase digest of sulfated CCK [CCK8(s)]. Automated amino acid sequencing was performed on a gas-phase sequencer (16) . Phenylthiohydantoin derivatives of amino acids were identified on an Ultrasphere C18 column (Beckman/Altex), as previously described (17) .
Bioassay. Synthetic CAP-9 (nonsulfated) and purified natural CAP-9 [fully sulfated; CAP-9(s,s)] were tested in the concentration range of 0.03 to 3 AuM in a dispersed guinea pig pancreatic acinar cell assay (18, 19) for their possible effect on amylase release. The bioassay was performed either in the absence of CCK8(s) or in the presence of 100 pM CCK8(s), which is the concentration producing half-maximal amylase release in this assay.
RESULTS
Immunoreactive CAP-9 was not measurable (<1 pmol/g) in the methanol extract of pig brain. After acid treatment the apparent immunoreactivity was increased to about 6 pmol/g, but a dilution curve of the acid-treated extract was not superposable on the synthetic CAP-9 standard curve (Fig. 1) . When synthetic CAP-9 was subjected to identical acid treatment, there was some loss in total immunoreactivity, but its dilution curve remained superposable on the untreated CAP-9 standard curve. After purification, CAP-9(s,s) was shown to be less than 0.3% as immunoreactive on a molar basis as nonsulfated synthetic CAP-9. Desulfated des-Ser9-CAP-9 Extract after acid desulfation was less than 5% as immunoreactive as nonsulfated CAP-9 in the assay system.
At each stage of purification portions of the eluates were desulfated by acid treatment and assayed. Since a dilution curve of the extract after acid treatment was not superposable on the CAP-9 standard, the concentrations at various steps of purification are subject to some error. Those elution fractions in which the desulfated aliquots contained immunoreactivity were pooled and subjected to the next stage of purification. The amounts shown are the concentration of immunoreactive CAP-9 measured in the treated aliquot multiplied by the volume of each fraction. Generally <1% of the eluate was acid-treated and used for assay.
The methanol extract of 8 kg of pig brain was concentrated by adsorption to a DEAE-cellulose column and eluted with a salt gradient (Fig. 2) . The peak elution fractions were pooled, and approximately one-fourth ofthe pool was further purified by a sequence of three HPLC steps (Fig. 3) . The final purification step yielded two peaks (A and B) with about equivalent UV absorbance at 214 nm. Peak A had an immunoreactive CAP-9 content equal to that expected from the UV absorbance. Peak B had only a few percent of the immunoreactivity expected from the UV absorbance.
The amino acid compositions of peaks A and B after 6 M HCl and leucine aminopeptidase hydrolysis are shown in Table 1 . Total enzyme hydrolysis reveals that the two tyrosines in both of the peptides are sulfated. In Fig. 4 the amino acid sequences of the peptides are compared with the sequences for rat, human, and pig COOH-terminal nonapeptides predicted from the respective cDNA with the difference that both of its tyrosines are modified by 0-sulfation. Peak B, like peak A, has both tyrosines 0-sulfated but lacks a serine at its COOH terminus.
The sulfated and nonsulfated nonapeptides showed no bioactivity in the guinea pig dispersed pancreatic acinar cell assay. They did not stimulate amylase release above basal levels in the concentration range of 0.03 to 3 ,uM nor did they augment or inhibit CCK8(s)-stimulated amylase release.
DISCUSSION
It has become increasingly more common to deduce the amino acid sequences of prepropeptides from their cDNA Antiserum 8393 was used at 1:100,000. B/F, bound/free. The cross-reactivity of dried and reconstituted methanol extract of pig brain in this assay is less than 1%. After acid desulfation, there is considerable increase in immunoreactivity, but a dilution curve is not superposable on the synthetic CAP-9 curve. The lack of superposability may be due to the presence of des-Ser9-CAP-9. Methanol extract from 8 kg of pig brain was concentrated on a 350-ml DE-52 DEAE-cellulose column and eluted with a salt gradient in 0.05 M Tris-HCl, pH 7. The eluates had no detectable immunoreactivity. However, a peak of immunoreactivity was detected when a small aliquot from each fraction was acid treated in a manner sufficient to desulfate tyrosines. The amounts shown are the total sulfated CAP-9 in the eluate. The table in the upper left gives the amount loaded on the column (In), the amount eluted (Out), and the recovery (R). This limitation is illustrated by CCK. The distributions of molecular forms of CCK differ strikingly between brain and duodenum (1) (2) (3) (4) (5) (6) (7) (8) , yet the cloned cDNA to CCK mRNA predicts identical preproCCKs in pig brain and gut (10) . Furthermore, while it is commonly accepted that the cleavage of bioactive peptides from precursors usually occurs at dibasic residues, predicting the post-translational cleavage of CCK is not straightforward. Only monobasic residues are adjacent to the NH2 termini of both CCK8 and CCK12. Yet CCK8 is the predominant biologically active form of CCK in brain while CCK12 is neither an intermediate nor a final molecular form (7) . Thus purification of peptides, direct determination of their sequences, and identification of peptide modifications are essential for complete identification of naturally occurring peptides.
The 114 amino acid preproCCK contains four tyrosine residues. One is located at the NH2 terminus of CCK39 and is preceded by an arginine; one is located within CCK8 and is preceded by an aspartic acid; and two are located in the COOH-terminal nonapeptide and are preceded by glutamic acid residues. In pig brain, the tyrosyl residue preceded by arginine is not O-sulfated, whereas the three tyrosines that are preceded by acidic amino acids are 0-sulfated. The proximity ofthe three sulfated tyrosine residues at the COOH terminus of the CCK precursor suggests that the same enzyme may be responsible for these three post-translational modification events and that the sulfation occurs before cleavage at the Arg-Arg site in the bridge between CCK8 and CAP-9. Recent reports have suggested that tyrosine-sulfated proteins belong mostly, if not exclusively, to one topological class: the bioactive secretorv nroteins (20) (21) (22) (23) (24) (25) 
